Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. - Wikidata - wikimedia - TriplyDB

Prevalence and characteristics of the metabolic syndrome in primary aldosteronism.

Prevalence and characteristics of the metabolic syndrome in primary aldosteronism.

http://www.wikidata.org/entity/Q46807615

about

Vascular disturbances in primary aldosteronism: clinical evidence Genetics of Aldosterone-Producing Adenoma in Korean Patients Primary Aldosteronism: Changing Definitions and New Concepts of Physiology and Pathophysiology Both Inside and Outside the Kidney.Intrarenal hemodynamics in primary aldosteronism before and after treatment.Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension.Aldosterone: role in the cardiometabolic syndrome and resistant hypertension Treating hypertension while protecting the vulnerable islet in the cardiometabolic syndrome Understanding primary aldosteronism: impact of next generation sequencing and expression profiling.The value of losartan suppression test in the confirmatory diagnosis of primary aldosteronism in patients over 50 years old Higher blood aldosterone level in metabolic syndrome is independently related to adiposity and fasting plasma glucose.Role of the Renin-Angiotensin system and aldosterone on cardiometabolic syndrome.Effect of low dose mineralocorticoid receptor antagonist eplerenone on glucose and lipid metabolism in healthy adult males Body mass index predicts aldosterone production in normotensive adults on a high-salt diet.The multifaceted mineralocorticoid receptor Visceral adipose tissue: emerging role of gluco- and mineralocorticoid hormones in the setting of cardiometabolic alterations Angiotensin 1-7 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model.Aldosterone and the risk of hypertension Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat.Primary aldosteronism: renaissance of a syndrome.Diagnosis and treatment of low-renin hypertension.Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.Predictors of successful outcome after adrenalectomy for primary aldosteronism.Resistant hypertension-complex mix of secondary causes and comorbidities Caveolin 1 Modulates Aldosterone-Mediated Pathways of Glucose and Lipid Homeostasis.Relationship between aldosterone and the metabolic syndrome in patients with obstructive sleep apnea hypopnea syndrome: effect of continuous positive airway pressure treatment.Mineralocorticoid receptor activation in obesity hypertension.Marine natural product des-O-methyllasiodiplodin effectively lowers the blood glucose level in db/db mice via ameliorating inflammation Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity.Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment.The role of aldosterone in the metabolic syndrome.Primary aldosteronism: A Japanese perspective.Treatment of primary aldosteronism: Where are we now?Mineralocorticoid receptor-associated hypertension and its organ damage: clinical relevance for resistant hypertension.Role of KCNJ5 in familial and sporadic primary aldosteronism.A critical review of the evidence supporting aldosterone in the etiology and its blockade in the treatment of obesity-associated hypertension.Elevated prevalence of abnormal glucose metabolism in patients with primary aldosteronism: a meta-analysis.Aldosterone excess and resistant hypertension: investigation and treatment.Pathophysiology, diagnosis, and treatment of mineralocorticoid disorders.The necessity and effectiveness of mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy.

P2860

Q26852612-916057B7-336C-4840-8C92-8D2760E6BF5F Q28552834-F42F9535-FC75-4762-A688-975586C13029 Q30248429-D6EF5F9D-892C-46C4-9550-7F5B41C6FC1C Q30482375-CF9E1EBD-FD50-4640-974E-797B53CC8B09 Q33579003-3989FC71-FBC7-465C-9FAB-3DE508353359 Q33667283-D21BA08D-C399-4A8F-BB16-3BC32BE3633B Q33736838-45A7CC15-3451-4A47-873D-83072CEAFBF0 Q33840829-06C588BF-7A3C-43AE-B3C5-9381A552E1D5 Q34850075-B59731CB-8E63-4E39-8CD9-0EAD38204C7A Q34978490-FF4455AD-4537-44B0-AD05-F69A04D78389 Q34997841-6BCFA2EA-60A2-4F47-988F-E6852BF1358F Q35113885-00010497-99D6-4A6B-83C7-1F19B01E0BFA Q35490517-D63D05D6-AA93-4BB1-B54B-9A2CA19E04AC Q35597066-3469F128-7101-4203-A47C-3F7005E269F1 Q35906989-E65AC42E-6616-4BE6-BF3A-DF5D5C4BB1E2 Q36297722-5F96EB0C-9945-47E1-A198-6A2422EEFA29 Q36720577-5B0CD502-51A3-40B6-8F6D-79B5BBBF45A0 Q36747846-5253F402-EF0B-41A7-BBE3-D3A3623C62FA Q36805476-3A507410-5FC1-40CA-B987-A8C179770170 Q36817162-19BAEEE9-67DA-4DC3-8160-4083D960B102 Q36851195-CD725937-ED7F-48D8-8CA3-42DBDB1DAE19 Q36857263-FAC9A38D-A728-4AE6-A9CB-CAD99B76AB47 Q37044839-9B3778EB-8152-4DC9-92BE-61F1F1A3822B Q37333220-088C0B34-E829-4D98-B1D9-76B1C0A22468 Q37434620-8231060A-1F8D-4EAE-8785-97742CEB572E Q37495691-F0FA8FAE-230B-46FD-ADAD-ADA6CBF61F26 Q37517178-2924BBEB-A535-48AC-83F0-BC1158484428 Q37727721-EA5A7AF6-6C08-4F5C-986F-63AFB1A63A99 Q37761303-629F2A38-3D8F-4C44-A577-4545848D263B Q37779717-007F930F-3984-4E75-A766-C87C6FBD5E6B Q37833554-32614663-2E39-42E0-9F68-84360F62D557 Q37838327-452B7311-EEED-4EEF-B77E-0BF9C8091CD9 Q37838328-263CBF24-1981-4B24-8D91-36562CB8E9AA Q37976974-F7B8C976-B067-4303-8C85-7B7499D296FF Q38066356-F4D05CF2-D1A7-4646-9329-C5531A61CEC2 Q38108677-2358A610-8ACE-494F-9D88-DA9833782C45 Q38132689-1533AAAB-786A-4A35-B83D-17CE02B47D8E Q38208961-88BC7431-E56A-4F52-837D-EC84DBE54967 Q38221451-AAFF308A-AC58-4346-978F-C31F522B8EC8 Q38374536-506F4B72-A827-4753-BC37-5E7EDE05431A

P2860

Prevalence and characteristics of the metabolic syndrome in primary aldosteronism.

http://www.wikidata.org/entity/Q46807615

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Prevalence and characteristics of the metabolic syndrome in primary aldosteronism.

@en

Prevalence and characteristics of the metabolic syndrome in primary aldosteronism.

@nl

type

label

Prevalence and characteristics of the metabolic syndrome in primary aldosteronism.

@en

Prevalence and characteristics of the metabolic syndrome in primary aldosteronism.

@nl

prefLabel

Prevalence and characteristics of the metabolic syndrome in primary aldosteronism.

@en

Prevalence and characteristics of the metabolic syndrome in primary aldosteronism.

@nl

P1433

Q46807615-F6A73A39-A5C5-42E2-83FE-443129CF396E

P1476

Q46807615-1A6DAA71-9590-4C46-9147-EDC0ED04CCD6

P2093

Q46807615-0EE1DF3F-CDE5-44D3-8916-C38C42543DE3

Q46807615-68AB5510-4C9A-4F6F-BDA5-0E583F2FCA1E

Q46807615-71440352-6435-4A0C-8BC2-99B5D9BDE1BF

Q46807615-7F3B6673-00ED-48D6-8FE3-896BE77FCF70

Q46807615-90B4F034-FBD8-4608-9F65-C45A0426BEF7

Q46807615-9AB6C2CB-B5A7-44D2-8E1D-A142B11FDB6D

Q46807615-9AEE3440-FFA4-4B12-A153-D920B453E2E0

Q46807615-CC2D3BEF-6600-459E-9E3A-ED2D98D02BDB

P304

Q46807615-0C22D09C-03C7-411A-9D7D-5627C3164065

P31

Q46807615-9463789D-E50D-4B91-8CEB-D425FD91419C

P356

Q46807615-857BCFF0-C989-4512-B36A-19ADF1B92314

P407

Q46807615-55AA17B9-170E-4DB1-9A4C-66F60D401173

P433

Q46807615-7E470DA9-E996-4B5C-81D7-3FA5310D3A35

P478

Q46807615-0E09E3A9-4A79-4469-B464-9D9B1F3E92AC

P50

Q46807615-3BE044A3-745C-4BC3-99B8-8E54D56A42F4

P577

Q46807615-0D1C6AA4-C607-4552-B9BD-99CF5763C56A

P5875

Q46807615-C118BE99-8F49-44B3-BC5E-D9421BE9F1B3

P698

Q46807615-2944E02F-45FD-4DAC-A513-0AC6B0728D46

P921

Q46807615-5930D364-1D1C-4B02-A142-E6432E7F78EC

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Prevalence and characteristics of the metabolic syndrome in primary aldosteronism.

@en

P2093

Chiara Bertello

http://www.w3.org/2001/XMLSchema#string

Francesco Fallo

http://www.w3.org/2001/XMLSchema#string

Franco Rabbia

http://www.w3.org/2001/XMLSchema#string

Franco Veglio

http://www.w3.org/2001/XMLSchema#string

Giovanni Federspil

http://www.w3.org/2001/XMLSchema#string

Mario Ermani

http://www.w3.org/2001/XMLSchema#string

Paolo Della Mea

http://www.w3.org/2001/XMLSchema#string

Paolo Mulatero

http://www.w3.org/2001/XMLSchema#string

P304

454-459

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2005-1733

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P50

Nicoletta Sonino

P577

2005-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7476253

http://www.w3.org/2001/XMLSchema#string

P698

16291704

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome